Clinical Trial Update: Antisense102: Pilot Immunotherapy for Newly Diagnosed Malignant Glioma [Phase 1]

View source ↗

Summary

An update reports the completion of a Phase 1 pilot immunotherapy trial (Antisense102) for newly diagnosed malignant glioma. The study evaluated Antisense102 in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Glioma

Drugs mentioned

• Antisense102

Snippet

Sponsor: david andrews | Conditions: Malignant Glioma, Neoplasms | Phase 1 | Status: COMPLETED